The global Active Tuberculosis Treatment market was valued at million in 2024 and is projected to reach US$ million by 2031, at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Active Tuberculosis Treatment manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Active Tuberculosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Active Tuberculosis Treatment. This report contains market size and forecasts of Active Tuberculosis Treatment in global, including the following market information:
Global Active Tuberculosis Treatment market revenue, 2020-2025, 2026-2031, ($ millions)
Global Active Tuberculosis Treatment market sales, 2020-2025, 2026-2031, (K Units)
Global top five Active Tuberculosis Treatment companies in 2024 (%)
Total Market by Segment:
Global Active Tuberculosis Treatment market, by Type, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Active Tuberculosis Treatment market segment percentages, by Type, 2024 (%)
Rifampin
Pyrazinamide
Ethambutol
Global Active Tuberculosis Treatment market, by Application, 2020-2025, 2026-2031 ($ Millions) & (K Units)
Global Active Tuberculosis Treatment market segment percentages, by Application, 2024 (%)
Hospital Pharmacies
Drug Stores and Retail Pharmacies
Online Pharmacies
Global Active Tuberculosis Treatment market, by region and country, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Active Tuberculosis Treatment market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Active Tuberculosis Treatment revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Active Tuberculosis Treatment revenues share in global market, 2024 (%)
Key companies Active Tuberculosis Treatment sales in global market, 2020-2025 (estimated), (K Units)
Key companies Active Tuberculosis Treatment sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lupin
Sanofi
Pfizer Inc.
FRESENIUS SE & Co
KGaA (Fresenius Kabi)
Johnson & Johnson
Novartis AG
Macleods Pharmaceuticals Ltd.
ANI Pharmaceuticals, Inc.
Otsuka Pharmaceutical Co., Ltd.
Teva Pharmaceutical Industries Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Active Tuberculosis Treatment, market overview.
Chapter 2: Global Active Tuberculosis Treatment market size in revenue and volume.
Chapter 3: Detailed analysis of Active Tuberculosis Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Active Tuberculosis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Active Tuberculosis Treatment capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Active Tuberculosis Treatment Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Active Tuberculosis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Active Tuberculosis Treatment Overall Market Size
2.1 Global Active Tuberculosis Treatment Market Size: 2024 VS 2031
2.2 Global Active Tuberculosis Treatment Market Size, Prospects & Forecasts: 2020-2031
2.3 Global Active Tuberculosis Treatment Sales: 2020-2031
3 Company Landscape
3.1 Top Active Tuberculosis Treatment Players in Global Market
3.2 Top Global Active Tuberculosis Treatment Companies Ranked by Revenue
3.3 Global Active Tuberculosis Treatment Revenue by Companies
3.4 Global Active Tuberculosis Treatment Sales by Companies
3.5 Global Active Tuberculosis Treatment Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Active Tuberculosis Treatment Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Active Tuberculosis Treatment Product Type
3.8 Tier 1, Tier 2, and Tier 3 Active Tuberculosis Treatment Players in Global Market
3.8.1 List of Global Tier 1 Active Tuberculosis Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Active Tuberculosis Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Active Tuberculosis Treatment Market Size Markets, 2024 & 2031
4.1.2 Rifampin
4.1.3 Pyrazinamide
4.1.4 Ethambutol
4.2 Segment by Type - Global Active Tuberculosis Treatment Revenue & Forecasts
4.2.1 Segment by Type - Global Active Tuberculosis Treatment Revenue, 2020-2025
4.2.2 Segment by Type - Global Active Tuberculosis Treatment Revenue, 2026-2031
4.2.3 Segment by Type - Global Active Tuberculosis Treatment Revenue Market Share, 2020-2031
4.3 Segment by Type - Global Active Tuberculosis Treatment Sales & Forecasts
4.3.1 Segment by Type - Global Active Tuberculosis Treatment Sales, 2020-2025
4.3.2 Segment by Type - Global Active Tuberculosis Treatment Sales, 2026-2031
4.3.3 Segment by Type - Global Active Tuberculosis Treatment Sales Market Share, 2020-2031
4.4 Segment by Type - Global Active Tuberculosis Treatment Price (Manufacturers Selling Prices), 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Active Tuberculosis Treatment Market Size, 2024 & 2031
5.1.2 Hospital Pharmacies
5.1.3 Drug Stores and Retail Pharmacies
5.1.4 Online Pharmacies
5.2 Segment by Application - Global Active Tuberculosis Treatment Revenue & Forecasts
5.2.1 Segment by Application - Global Active Tuberculosis Treatment Revenue, 2020-2025
5.2.2 Segment by Application - Global Active Tuberculosis Treatment Revenue, 2026-2031
5.2.3 Segment by Application - Global Active Tuberculosis Treatment Revenue Market Share, 2020-2031
5.3 Segment by Application - Global Active Tuberculosis Treatment Sales & Forecasts
5.3.1 Segment by Application - Global Active Tuberculosis Treatment Sales, 2020-2025
5.3.2 Segment by Application - Global Active Tuberculosis Treatment Sales, 2026-2031
5.3.3 Segment by Application - Global Active Tuberculosis Treatment Sales Market Share, 2020-2031
5.4 Segment by Application - Global Active Tuberculosis Treatment Price (Manufacturers Selling Prices), 2020-2031
6 Sights by Region
6.1 By Region - Global Active Tuberculosis Treatment Market Size, 2024 & 2031
6.2 By Region - Global Active Tuberculosis Treatment Revenue & Forecasts
6.2.1 By Region - Global Active Tuberculosis Treatment Revenue, 2020-2025
6.2.2 By Region - Global Active Tuberculosis Treatment Revenue, 2026-2031
6.2.3 By Region - Global Active Tuberculosis Treatment Revenue Market Share, 2020-2031
6.3 By Region - Global Active Tuberculosis Treatment Sales & Forecasts
6.3.1 By Region - Global Active Tuberculosis Treatment Sales, 2020-2025
6.3.2 By Region - Global Active Tuberculosis Treatment Sales, 2026-2031
6.3.3 By Region - Global Active Tuberculosis Treatment Sales Market Share, 2020-2031
6.4 North America
6.4.1 By Country - North America Active Tuberculosis Treatment Revenue, 2020-2031
6.4.2 By Country - North America Active Tuberculosis Treatment Sales, 2020-2031
6.4.3 United States Active Tuberculosis Treatment Market Size, 2020-2031
6.4.4 Canada Active Tuberculosis Treatment Market Size, 2020-2031
6.4.5 Mexico Active Tuberculosis Treatment Market Size, 2020-2031
6.5 Europe
6.5.1 By Country - Europe Active Tuberculosis Treatment Revenue, 2020-2031
6.5.2 By Country - Europe Active Tuberculosis Treatment Sales, 2020-2031
6.5.3 Germany Active Tuberculosis Treatment Market Size, 2020-2031
6.5.4 France Active Tuberculosis Treatment Market Size, 2020-2031
6.5.5 U.K. Active Tuberculosis Treatment Market Size, 2020-2031
6.5.6 Italy Active Tuberculosis Treatment Market Size, 2020-2031
6.5.7 Russia Active Tuberculosis Treatment Market Size, 2020-2031
6.5.8 Nordic Countries Active Tuberculosis Treatment Market Size, 2020-2031
6.5.9 Benelux Active Tuberculosis Treatment Market Size, 2020-2031
6.6 Asia
6.6.1 By Region - Asia Active Tuberculosis Treatment Revenue, 2020-2031
6.6.2 By Region - Asia Active Tuberculosis Treatment Sales, 2020-2031
6.6.3 China Active Tuberculosis Treatment Market Size, 2020-2031
6.6.4 Japan Active Tuberculosis Treatment Market Size, 2020-2031
6.6.5 South Korea Active Tuberculosis Treatment Market Size, 2020-2031
6.6.6 Southeast Asia Active Tuberculosis Treatment Market Size, 2020-2031
6.6.7 India Active Tuberculosis Treatment Market Size, 2020-2031
6.7 South America
6.7.1 By Country - South America Active Tuberculosis Treatment Revenue, 2020-2031
6.7.2 By Country - South America Active Tuberculosis Treatment Sales, 2020-2031
6.7.3 Brazil Active Tuberculosis Treatment Market Size, 2020-2031
6.7.4 Argentina Active Tuberculosis Treatment Market Size, 2020-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Active Tuberculosis Treatment Revenue, 2020-2031
6.8.2 By Country - Middle East & Africa Active Tuberculosis Treatment Sales, 2020-2031
6.8.3 Turkey Active Tuberculosis Treatment Market Size, 2020-2031
6.8.4 Israel Active Tuberculosis Treatment Market Size, 2020-2031
6.8.5 Saudi Arabia Active Tuberculosis Treatment Market Size, 2020-2031
6.8.6 UAE Active Tuberculosis Treatment Market Size, 2020-2031
7 Manufacturers & Brands Profiles
7.1 Lupin
7.1.1 Lupin Company Summary
7.1.2 Lupin Business Overview
7.1.3 Lupin Active Tuberculosis Treatment Major Product Offerings
7.1.4 Lupin Active Tuberculosis Treatment Sales and Revenue in Global (2020-2025)
7.1.5 Lupin Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Active Tuberculosis Treatment Major Product Offerings
7.2.4 Sanofi Active Tuberculosis Treatment Sales and Revenue in Global (2020-2025)
7.2.5 Sanofi Key News & Latest Developments
7.3 Pfizer Inc.
7.3.1 Pfizer Inc. Company Summary
7.3.2 Pfizer Inc. Business Overview
7.3.3 Pfizer Inc. Active Tuberculosis Treatment Major Product Offerings
7.3.4 Pfizer Inc. Active Tuberculosis Treatment Sales and Revenue in Global (2020-2025)
7.3.5 Pfizer Inc. Key News & Latest Developments
7.4 FRESENIUS SE & Co
7.4.1 FRESENIUS SE & Co Company Summary
7.4.2 FRESENIUS SE & Co Business Overview
7.4.3 FRESENIUS SE & Co Active Tuberculosis Treatment Major Product Offerings
7.4.4 FRESENIUS SE & Co Active Tuberculosis Treatment Sales and Revenue in Global (2020-2025)
7.4.5 FRESENIUS SE & Co Key News & Latest Developments
7.5 KGaA (Fresenius Kabi)
7.5.1 KGaA (Fresenius Kabi) Company Summary
7.5.2 KGaA (Fresenius Kabi) Business Overview
7.5.3 KGaA (Fresenius Kabi) Active Tuberculosis Treatment Major Product Offerings
7.5.4 KGaA (Fresenius Kabi) Active Tuberculosis Treatment Sales and Revenue in Global (2020-2025)
7.5.5 KGaA (Fresenius Kabi) Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Active Tuberculosis Treatment Major Product Offerings
7.6.4 Johnson & Johnson Active Tuberculosis Treatment Sales and Revenue in Global (2020-2025)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 Novartis AG
7.7.1 Novartis AG Company Summary
7.7.2 Novartis AG Business Overview
7.7.3 Novartis AG Active Tuberculosis Treatment Major Product Offerings
7.7.4 Novartis AG Active Tuberculosis Treatment Sales and Revenue in Global (2020-2025)
7.7.5 Novartis AG Key News & Latest Developments
7.8 Macleods Pharmaceuticals Ltd.
7.8.1 Macleods Pharmaceuticals Ltd. Company Summary
7.8.2 Macleods Pharmaceuticals Ltd. Business Overview
7.8.3 Macleods Pharmaceuticals Ltd. Active Tuberculosis Treatment Major Product Offerings
7.8.4 Macleods Pharmaceuticals Ltd. Active Tuberculosis Treatment Sales and Revenue in Global (2020-2025)
7.8.5 Macleods Pharmaceuticals Ltd. Key News & Latest Developments
7.9 ANI Pharmaceuticals, Inc.
7.9.1 ANI Pharmaceuticals, Inc. Company Summary
7.9.2 ANI Pharmaceuticals, Inc. Business Overview
7.9.3 ANI Pharmaceuticals, Inc. Active Tuberculosis Treatment Major Product Offerings
7.9.4 ANI Pharmaceuticals, Inc. Active Tuberculosis Treatment Sales and Revenue in Global (2020-2025)
7.9.5 ANI Pharmaceuticals, Inc. Key News & Latest Developments
7.10 Otsuka Pharmaceutical Co., Ltd.
7.10.1 Otsuka Pharmaceutical Co., Ltd. Company Summary
7.10.2 Otsuka Pharmaceutical Co., Ltd. Business Overview
7.10.3 Otsuka Pharmaceutical Co., Ltd. Active Tuberculosis Treatment Major Product Offerings
7.10.4 Otsuka Pharmaceutical Co., Ltd. Active Tuberculosis Treatment Sales and Revenue in Global (2020-2025)
7.10.5 Otsuka Pharmaceutical Co., Ltd. Key News & Latest Developments
7.11 Teva Pharmaceutical Industries Ltd.
7.11.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.11.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.11.3 Teva Pharmaceutical Industries Ltd. Active Tuberculosis Treatment Major Product Offerings
7.11.4 Teva Pharmaceutical Industries Ltd. Active Tuberculosis Treatment Sales and Revenue in Global (2020-2025)
7.11.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
8 Global Active Tuberculosis Treatment Production Capacity, Analysis
8.1 Global Active Tuberculosis Treatment Production Capacity, 2020-2031
8.2 Active Tuberculosis Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Active Tuberculosis Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Active Tuberculosis Treatment Supply Chain Analysis
10.1 Active Tuberculosis Treatment Industry Value Chain
10.2 Active Tuberculosis Treatment Upstream Market
10.3 Active Tuberculosis Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Active Tuberculosis Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Active Tuberculosis Treatment in Global Market
Table 2. Top Active Tuberculosis Treatment Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Active Tuberculosis Treatment Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Active Tuberculosis Treatment Revenue Share by Companies, 2020-2025
Table 5. Global Active Tuberculosis Treatment Sales by Companies, (K Units), 2020-2025
Table 6. Global Active Tuberculosis Treatment Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Active Tuberculosis Treatment Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Active Tuberculosis Treatment Product Type
Table 9. List of Global Tier 1 Active Tuberculosis Treatment Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Active Tuberculosis Treatment Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type – Global Active Tuberculosis Treatment Revenue, (US$, Mn), 2024 & 2031
Table 12. Segment by Type - Global Active Tuberculosis Treatment Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Active Tuberculosis Treatment Revenue (US$, Mn), 2026-2031
Table 14. Segment by Type - Global Active Tuberculosis Treatment Sales (K Units), 2020-2025
Table 15. Segment by Type - Global Active Tuberculosis Treatment Sales (K Units), 2026-2031
Table 16. Segment by Application – Global Active Tuberculosis Treatment Revenue, (US$, Mn), 2024 & 2031
Table 17. Segment by Application - Global Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Active Tuberculosis Treatment Revenue, (US$, Mn), 2026-2031
Table 19. Segment by Application - Global Active Tuberculosis Treatment Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global Active Tuberculosis Treatment Sales, (K Units), 2026-2031
Table 21. By Region – Global Active Tuberculosis Treatment Revenue, (US$, Mn), 2025-2031
Table 22. By Region - Global Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Active Tuberculosis Treatment Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Global Active Tuberculosis Treatment Sales, (K Units), 2020-2025
Table 25. By Region - Global Active Tuberculosis Treatment Sales, (K Units), 2026-2031
Table 26. By Country - North America Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Active Tuberculosis Treatment Revenue, (US$, Mn), 2026-2031
Table 28. By Country - North America Active Tuberculosis Treatment Sales, (K Units), 2020-2025
Table 29. By Country - North America Active Tuberculosis Treatment Sales, (K Units), 2026-2031
Table 30. By Country - Europe Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Active Tuberculosis Treatment Revenue, (US$, Mn), 2026-2031
Table 32. By Country - Europe Active Tuberculosis Treatment Sales, (K Units), 2020-2025
Table 33. By Country - Europe Active Tuberculosis Treatment Sales, (K Units), 2026-2031
Table 34. By Region - Asia Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Active Tuberculosis Treatment Revenue, (US$, Mn), 2026-2031
Table 36. By Region - Asia Active Tuberculosis Treatment Sales, (K Units), 2020-2025
Table 37. By Region - Asia Active Tuberculosis Treatment Sales, (K Units), 2026-2031
Table 38. By Country - South America Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Active Tuberculosis Treatment Revenue, (US$, Mn), 2026-2031
Table 40. By Country - South America Active Tuberculosis Treatment Sales, (K Units), 2020-2025
Table 41. By Country - South America Active Tuberculosis Treatment Sales, (K Units), 2026-2031
Table 42. By Country - Middle East & Africa Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Active Tuberculosis Treatment Revenue, (US$, Mn), 2026-2031
Table 44. By Country - Middle East & Africa Active Tuberculosis Treatment Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa Active Tuberculosis Treatment Sales, (K Units), 2026-2031
Table 46. Lupin Company Summary
Table 47. Lupin Active Tuberculosis Treatment Product Offerings
Table 48. Lupin Active Tuberculosis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Lupin Key News & Latest Developments
Table 50. Sanofi Company Summary
Table 51. Sanofi Active Tuberculosis Treatment Product Offerings
Table 52. Sanofi Active Tuberculosis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. Sanofi Key News & Latest Developments
Table 54. Pfizer Inc. Company Summary
Table 55. Pfizer Inc. Active Tuberculosis Treatment Product Offerings
Table 56. Pfizer Inc. Active Tuberculosis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Pfizer Inc. Key News & Latest Developments
Table 58. FRESENIUS SE & Co Company Summary
Table 59. FRESENIUS SE & Co Active Tuberculosis Treatment Product Offerings
Table 60. FRESENIUS SE & Co Active Tuberculosis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. FRESENIUS SE & Co Key News & Latest Developments
Table 62. KGaA (Fresenius Kabi) Company Summary
Table 63. KGaA (Fresenius Kabi) Active Tuberculosis Treatment Product Offerings
Table 64. KGaA (Fresenius Kabi) Active Tuberculosis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. KGaA (Fresenius Kabi) Key News & Latest Developments
Table 66. Johnson & Johnson Company Summary
Table 67. Johnson & Johnson Active Tuberculosis Treatment Product Offerings
Table 68. Johnson & Johnson Active Tuberculosis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Johnson & Johnson Key News & Latest Developments
Table 70. Novartis AG Company Summary
Table 71. Novartis AG Active Tuberculosis Treatment Product Offerings
Table 72. Novartis AG Active Tuberculosis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. Novartis AG Key News & Latest Developments
Table 74. Macleods Pharmaceuticals Ltd. Company Summary
Table 75. Macleods Pharmaceuticals Ltd. Active Tuberculosis Treatment Product Offerings
Table 76. Macleods Pharmaceuticals Ltd. Active Tuberculosis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 77. Macleods Pharmaceuticals Ltd. Key News & Latest Developments
Table 78. ANI Pharmaceuticals, Inc. Company Summary
Table 79. ANI Pharmaceuticals, Inc. Active Tuberculosis Treatment Product Offerings
Table 80. ANI Pharmaceuticals, Inc. Active Tuberculosis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 81. ANI Pharmaceuticals, Inc. Key News & Latest Developments
Table 82. Otsuka Pharmaceutical Co., Ltd. Company Summary
Table 83. Otsuka Pharmaceutical Co., Ltd. Active Tuberculosis Treatment Product Offerings
Table 84. Otsuka Pharmaceutical Co., Ltd. Active Tuberculosis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 85. Otsuka Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 86. Teva Pharmaceutical Industries Ltd. Company Summary
Table 87. Teva Pharmaceutical Industries Ltd. Active Tuberculosis Treatment Product Offerings
Table 88. Teva Pharmaceutical Industries Ltd. Active Tuberculosis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 89. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 90. Active Tuberculosis Treatment Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 91. Global Active Tuberculosis Treatment Capacity Market Share of Key Manufacturers, 2023-2025
Table 92. Global Active Tuberculosis Treatment Production by Region, 2020-2025 (K Units)
Table 93. Global Active Tuberculosis Treatment Production by Region, 2026-2031 (K Units)
Table 94. Active Tuberculosis Treatment Market Opportunities & Trends in Global Market
Table 95. Active Tuberculosis Treatment Market Drivers in Global Market
Table 96. Active Tuberculosis Treatment Market Restraints in Global Market
Table 97. Active Tuberculosis Treatment Raw Materials
Table 98. Active Tuberculosis Treatment Raw Materials Suppliers in Global Market
Table 99. Typical Active Tuberculosis Treatment Downstream
Table 100. Active Tuberculosis Treatment Downstream Clients in Global Market
Table 101. Active Tuberculosis Treatment Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Active Tuberculosis Treatment Product Picture
Figure 2. Active Tuberculosis Treatment Segment by Type in 2024
Figure 3. Active Tuberculosis Treatment Segment by Application in 2024
Figure 4. Global Active Tuberculosis Treatment Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Active Tuberculosis Treatment Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Active Tuberculosis Treatment Revenue: 2020-2031 (US$, Mn)
Figure 8. Active Tuberculosis Treatment Sales in Global Market: 2020-2031 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Active Tuberculosis Treatment Revenue in 2024
Figure 10. Segment by Type – Global Active Tuberculosis Treatment Revenue, (US$, Mn), 2024 & 2031
Figure 11. Segment by Type - Global Active Tuberculosis Treatment Revenue Market Share, 2020-2031
Figure 12. Segment by Type - Global Active Tuberculosis Treatment Sales Market Share, 2020-2031
Figure 13. Segment by Type - Global Active Tuberculosis Treatment Price (US$/Unit), 2020-2031
Figure 14. Segment by Application – Global Active Tuberculosis Treatment Revenue, (US$, Mn), 2024 & 2031
Figure 15. Segment by Application - Global Active Tuberculosis Treatment Revenue Market Share, 2020-2031
Figure 16. Segment by Application - Global Active Tuberculosis Treatment Sales Market Share, 2020-2031
Figure 17. Segment by Application -Global Active Tuberculosis Treatment Price (US$/Unit), 2020-2031
Figure 18. By Region – Global Active Tuberculosis Treatment Revenue, (US$, Mn), 2025 & 2031
Figure 19. By Region - Global Active Tuberculosis Treatment Revenue Market Share, 2020 VS 2024 VS 2031
Figure 20. By Region - Global Active Tuberculosis Treatment Revenue Market Share, 2020-2031
Figure 21. By Region - Global Active Tuberculosis Treatment Sales Market Share, 2020-2031
Figure 22. By Country - North America Active Tuberculosis Treatment Revenue Market Share, 2020-2031
Figure 23. By Country - North America Active Tuberculosis Treatment Sales Market Share, 2020-2031
Figure 24. United States Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2031
Figure 25. Canada Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2031
Figure 26. Mexico Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2031
Figure 27. By Country - Europe Active Tuberculosis Treatment Revenue Market Share, 2020-2031
Figure 28. By Country - Europe Active Tuberculosis Treatment Sales Market Share, 2020-2031
Figure 29. Germany Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2031
Figure 30. France Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2031
Figure 31. U.K. Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2031
Figure 32. Italy Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2031
Figure 33. Russia Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2031
Figure 34. Nordic Countries Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2031
Figure 35. Benelux Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2031
Figure 36. By Region - Asia Active Tuberculosis Treatment Revenue Market Share, 2020-2031
Figure 37. By Region - Asia Active Tuberculosis Treatment Sales Market Share, 2020-2031
Figure 38. China Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2031
Figure 39. Japan Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2031
Figure 40. South Korea Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2031
Figure 41. Southeast Asia Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2031
Figure 42. India Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2031
Figure 43. By Country - South America Active Tuberculosis Treatment Revenue Market Share, 2020-2031
Figure 44. By Country - South America Active Tuberculosis Treatment Sales, Market Share, 2020-2031
Figure 45. Brazil Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2031
Figure 46. Argentina Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2031
Figure 47. By Country - Middle East & Africa Active Tuberculosis Treatment Revenue, Market Share, 2020-2031
Figure 48. By Country - Middle East & Africa Active Tuberculosis Treatment Sales, Market Share, 2020-2031
Figure 49. Turkey Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2031
Figure 50. Israel Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2031
Figure 51. Saudi Arabia Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2031
Figure 52. UAE Active Tuberculosis Treatment Revenue, (US$, Mn), 2020-2031
Figure 53. Global Active Tuberculosis Treatment Production Capacity (K Units), 2020-2031
Figure 54. The Percentage of Production Active Tuberculosis Treatment by Region, 2024 VS 2031
Figure 55. Active Tuberculosis Treatment Industry Value Chain
Figure 56. Marketing Channels
